FDA Limits Use Of Johnson & Johnson Vaccine Due To Blood Clot Risk

Johnson & Johnson’s coronavirus vaccine is now only authorized for U.S. adults who are unable to receive other vaccines, the Food and Drug Administration announced Thursday, citing the Johnson & Johnson vaccine’s risk of potentially life-threatening blood clotting side effects.